Cetacea

Cetacea is a pre-clinical stage biotechnology company focused on developing novel small molecule therapeutics for metabolic disorders, including obesity and type 2 diabetes. The company leverages a proprietary drug discovery platform centered on G protein-coupled receptors (GPCRs) to identify and optimize candidates with improved efficacy and safety profiles. By targeting specific GPCR pathways involved in energy homeostasis and glucose regulation, Cetacea aims to address significant unmet needs in the metabolic health landscape. The company's research is grounded in deep expertise in receptor pharmacology and medicinal chemistry.